1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. United States >
  5. Massachusetts >
  6. Opko Acquires ModeX Therapeutics

M&A Deal Summary

Opko Acquires ModeX Therapeutics

On May 9, 2022, Opko acquired life science company ModeX Therapeutics for 300M USD

Acquisition Highlights
  • This is Opko’s 9th transaction in the Life Science sector.
  • This is Opko’s 3rd largest (disclosed) transaction.
  • This is Opko’s 7th transaction in the United States.
  • This is Opko’s 2nd transaction in Massachusetts.

M&A Deal Summary
Date 2022-05-09
Target ModeX Therapeutics
Sector Life Science
Buyer(s) Opko
Deal Type Add-on Acquisition
Deal Value 300M USD

Target

ModeX Therapeutics

Natick, Massachusetts, United States
ModeX Therapeutics has developed highly flexible multi-specific antibody technology platforms with broad targeting and functional capabilities, simpler manufacturing, and potentially better specificity and safety, providing significant differentiation from competing platforms. ModeX Therapeutics was founded in October 2020 with headquarters in Natick, Massachusetts.

Search 214,239 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Opko

Miami, Florida, United States
Category Company
Founded 1991
Sector Life Science
Employees2,997
Revenue 713M USD (2024)
DESCRIPTION
Opko's corporate headquarters in Miami, Florida.
Opko's corporate headquarters in Miami, Florida.

Opko is a diversified healthcare company with a focus on establishing leading positions in significant and rapidly growing medical markets. Opko's operations are divided into diagnostics and pharmaceuticals, each with specialized products and services aimed at improving patient care and outcomes. Opko was founded in 1991 and is based in Miami, Florida.

DEAL STATS #
Overall 20 of 20
Sector: Life Science M&A 9 of 9
Type: Add-on Acquisition M&A Deals 18 of 18
State: Massachusetts M&A 2 of 2
Country: United States M&A 7 of 7
Year: 2022 M&A 1 of 1
Size (of disclosed) 3 of 6
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2021-06-17 OPKO Health - Sterile Fill & Finish Manufacturing Facility

Waterford, Ireland

OPKO Health - Sterile Fill & Finish Manufacturing Facility engages in the development and commercial supply of high potency, high barrier to entry, pharmaceutical products for sale.

Sell $65M
Mergr

Solution for

Product

Company

Legal